AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • February 22nd, 2024 • Karuna Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This Amended and Restated Employment Agreement (“Agreement”) is made between Karuna Therapeutics, Inc., a Delaware corporation (the “Company”), and William Kane (the “Executive”) and is made effective as of December 22, 2023 (the “Effective Date”).
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. SAB ADVISOR AGREEMENTSab Advisor Agreement • February 22nd, 2024 • Karuna Therapeutics, Inc. • Pharmaceutical preparations
This SAB ADVISOR AGREEMENT (“Agreement”), made this January 16, 2024 (the “Effective Date”), is entered into by Karuna Therapeutics, Inc., a Delaware corporation (the “Company”), and Steven Paul, M.D. (“Advisor”).
RESTRICTED STOCK UNIT AWARD AGREEMENT FOR COMPANY EMPLOYEES UNDER KARUNA THERAPEUTICS, INC. 2019 STOCK OPTION AND INCENTIVE PLANRestricted Stock Unit Award Agreement • February 22nd, 2024 • Karuna Therapeutics, Inc. • Pharmaceutical preparations
Pursuant to the Karuna Therapeutics, Inc. 2019 Stock Option and Incentive Plan as amended through the date hereof (the “Plan”), Karuna Therapeutics, Inc. (the “Company”) hereby grants an award of the number of Restricted Stock Units listed above (an “Award”) to the Grantee named above. Each Restricted Stock Unit shall relate to one share of Common Stock, par value $0.0001 per share (the “Stock”) of the Company.
